|
Definitions P
p24: A protein in HIV's inner core. The p24 antigen
test looks for the presence of this protein in a patient's blood.
Parenteral: Administered by infusion or injection.
Pathogenesis: The origin and development of a
disease.
PBMC (peripheral blood mononuclear cell): Cells in
the bloodstream with one nucleus.
Peptide: A short compound formed by the linkage of
two or more amino acids. Proteins are made of multiple peptides.
PHA (phytohemagglutinin): A plant chemical used to
stimulate the multiplication of white blood cells.
Pharmacokinetics: The processes of absorption,
distribution, metabolism and excretion of a drug or vaccine.
Placebo: An inactive substance administered to some
study participants while others receive the agent under evaluation, to provide a basis for
comparison of effects.
Polymerase: An enzyme that promotes synthesis of
segments of genetic material, either RNA or DNA.
Polymerase chain reaction (PCR): A sensitive
technique that can detect and quantify HIV in a person's blood or lymph nodes.
Polyvalent vaccine: A vaccine that is protective
against multiple viral strains.
Prevalence: The number of people in a population
affected with a particular disease at a given time.
Prophylaxis: Prevention of disease.
Protocol: The detailed plan for a clinical trial
that states the trial's rationale, purpose, drug or vaccine dosages, length of study,
routes of administration, who may participate and other aspects of trial design.
Pseudovirion: A virus-like particle.
Previous | Contents | Next
|